AR and metabolic dysfunction-associated steatohepatitis: Another study reported that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), cooperates with obesity-induced pro-inflammatory signaling to promote NASH-related hepatocarcinogenesis.